Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension
NCT03006471Phase 4Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Mar 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in prediabetes, prehypertension, sponsored by Universidad de Guadalajara. Started Mar 2016; status: completed.
02
Drugs
dapagliflozin
03
Conditions
prediabetesprehypertension
Beyond the preview
Go deeper on NCT03006471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006471.